Dominika Gacka

Dominika Gacka

Auto-generated profile, based on publicly available information

Dominika Gacka

Szpital Morski Im. PCK, Gdynia, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KGKatarzyna Gondek
Katarzyna Gondek
MWMaria Wojcieszek
Maria Wojcieszek
MCMaksymilian Czarnota
Maksymilian Czarnota
DGDominika Gacka
Dominika Gacka
MFMagdalena Fidelis
Magdalena Fidelis
ZTZuzanna Tanç
Zuzanna Tanç
Down syndrome (DS), or trisomy 21, is the most common chromosomal disorder, characterized by intellectual disability, congenital anomalies, and an increased risk of neurodegenerative diseases. This review synthesizes current knowledge on the etiology, clinical presentation, and modern therapeutic strategies for DS, including early intervention, medical management, and psychosocial support. Particular emphasis is placed on the revolutionary potential of CRISPR-Cas gene-editing technology as a tool for future treatment strategies. Drawing upon findings from many scientific publications, the article discusses the mechanism of CRISPR, its current medical applications, and its experimental use in silencing the extra chromosome 21 or correcting DS-associated genes. Technical, ethical, and delivery-related limitations are explored, alongside speculative but promising research directions, including base editing, prime editing, and cerebral organoids. The article concludes with a reflection on whether societal perceptions of genetic diversity should evolve alongside scientific innovation, highlighting that the greatest breakthrough may come not from altering genomes, but from fostering inclusion and understanding.

30 June 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MCMaksymilian Czarnota
Maksymilian Czarnota
MWMaria Wojcieszek
Maria Wojcieszek
DGDominika Gacka
Dominika Gacka
AŻAleksandra Żołnierek
Aleksandra Żołnierek
KGKatarzyna Gondek
Katarzyna Gondek
ZTZuzanna Tanç
Zuzanna Tanç
Thyroid health is intricately linked to nutritional status, as multiple micronutrients and dietary components modulate hormone biosynthesis, metabolism, and immune function. The increasing global prevalence of autoimmune thyroid disorders, particularly Hashimoto’s thyroiditis and Graves’ disease, underscores the need to examine the influence of modifiable dietary factors on thyroid pathophysiology. This narrative review aimed to evaluate current evidence on the role of nutrition—especially micronutrients such as iodine, selenium, iron, zinc, and vitamin D—in thyroid function and autoimmunity. A structured literature search was conducted using PubMed and Scopus to identify relevant human studies published between January 2002 and March 2025. A total of forty-one peer-reviewed articles were selected based on predefined inclusion criteria and assessed for scientific rigor and relevance. The evidence confirms the critical involvement of iodine and selenium in thyroid hormone synthesis and immune modulation, while iron and zinc were found to support enzymatic activity and endocrine stability. Vitamin D emerged as a potential immunoregulatory agent in autoimmune thyroid disease. Furthermore, certain macronutrients—including high-quality proteins, fiber, and omega-3 fatty acids—as well as dietary patterns such as the Mediterranean diet, were associated with favorable thyroid outcomes. Conversely, the intake of goitrogenic foods and soy isoflavones may necessitate caution in predisposed individuals. These findings highlight the relevance of individualized, evidence-based nutritional strategies as adjunctive approaches in the prevention and clinical management of thyroid disorders.

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MFMagdalena Fidelis
Magdalena Fidelis
AZAgnieszka Zalewska
Agnieszka Zalewska
MZMaria Zadrożna-Dyńka
Maria Zadrożna-Dyńka
MDMarcin Dyńka
Marcin Dyńka
MWMaria Wojcieszek
Maria Wojcieszek
ZTZuzanna Tanç
Zuzanna Tanç
The global shift to remote and hybrid work models from 2021 to 2025, comparable to the Industrial Revolution in scale, has entrenched flexibility while introducing unintended physiological, psychological, and sociological costs. This narrative review synthesizes data from the International Labour Organization, World Health Organization, Eurofound, and peer-reviewed literature (2020-2025) to analyze these externalities among college-educated workers. Drawing on the Global Survey of Working Arrangements (G-SWA), work-from-home stabilized at 1.27 days/week globally (27% of U.S. workdays), with regional disparities (e.g., 1.5-1.9 days in English-speaking economies vs. 0.5-1.0 in Asia) influencing exposure. The "Infinite Workday" (Microsoft, 2025) - characterized by 117 emails, 153 Teams messages, and 275 daily interruptions - exacerbates issues like Work-Related Musculoskeletal Disorders (WRMSDs, prevalence 61.2%-72%, e.g., neck pain 50.4%-58.9%) and Computer Vision Syndrome (CVS, pooled 69.0%, 95% CI 62.3-75.3). Psychologically, technostress (50-70% prevalence for techno-overload) and Zoom fatigue (40-70%) blur boundaries, while sedentary isolation elevates inflammation (CRP/IL-6) and depression risk (20-43%). Sociologically, women face double burdens (promotion gap 37% vs. 49% for men), Gen Z reports 27% loneliness, and individualism explains 29% WFH variance. Economically, costs include $380.9 billion U.S. MSK healthcare and $9.6 trillion global disengagement opportunity (Gallup, 2025). Without ergonomic (e.g., TuMeke's 42% injury reduction), policy ("Right to Disconnect" reducing stress 10-30%), and cultural interventions, flexibility's dividends risk erosion by chronic morbidity.

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MFMagdalena Fidelis
Magdalena Fidelis
AZAgnieszka Zalewska
Agnieszka Zalewska
MZMaria Zadrożna-Dyńka
Maria Zadrożna-Dyńka
MDMarcin Dyńka
Marcin Dyńka
MWMaria Wojcieszek
Maria Wojcieszek
ZTZuzanna Tanç
Zuzanna Tanç
Global plastic production has led to widespread environmental contamination, with synthetic polymers fragmenting into microplastics (MPs) and nanoplastics (NPs). These particles have been detected in human tissues, raising questions about their health effects. This narrative review synthesizes biomonitoring studies on MP/NP accumulation, with a focus on reproductive systems. Data from recent research show polymers in blood, lungs, placentas, breast milk, testes, and brain, linked to exposure routes such as inhalation and ingestion. The review examines potential translocation across barriers like the placenta and blood-brain barrier, as well as toxicity mechanisms, including endocrine-disrupting chemical release, oxidative stress via the Nrf2 pathway, and cellular disruption. In reproductive health, evidence indicates MP presence in ovarian follicular fluid and associations with reduced sperm quality, suggesting potential contributions to fertility trends. The review also addresses debates on neuro-accumulation and economic costs of related diseases. Findings highlight MPs as a public health concern, calling for policy measures and updated risk assessments.

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
AMAleksandra Mączyńska
Aleksandra Mączyńska
MZMarta Zawadzka
Marta Zawadzka
MWMaria Wojcieszek
Maria Wojcieszek
MCMaksymilian Czarnota
Maksymilian Czarnota
MFMagdalena Fidelis
Magdalena Fidelis
KGKatarzyna Gondek
Katarzyna Gondek
The emergence of zoonotic viral diseases has significantly impacted public health, the global economy, and societal structures in recent years. The World Health Organization's 2024 updated R&D Blueprint report identifies infectious agents posing the greatest epidemiological threats. Among them is the Nipah virus (NiV), a highly lethal paramyxovirus naturally harboured by fruit bats, which typically causes severe respiratory distress and encephalitis in humans. Moreover, the NiV exhibits the capacity to infect a wide range of mammalian species, including livestock and domestic pets. The secretions and excretions of these animals can potentially serve as sources of human infection. This presents both a direct health risk and an indirect one, due to losses in agriculture and associated economic consequences. After the first outbreak in Malaysia (1998–1999), in addition to decontamination measures, mass culling of pigs was carried out. Although Malaysia has been declared free of NiV infection, new cases continue to emerge almost annually in Bangladesh and India, with the most recent reported in 2025. Given the current scale of human migration, the global nature of food transportation, and other facets of globalization, it is imperative to prepare for the potential spread of the disease of a magnitude similar to COVID-19. To date, no targeted therapies or vaccines have been approved. Given this situation, the primary objective of the present work is to raise awareness among clinicians regarding the characteristics and pathogenicity of NiV, as well as the practical aspects related to the recognition, diagnosis, and treatment of the infection.

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MFMagdalena Fidelis
Magdalena Fidelis
MWMaria Wojcieszek
Maria Wojcieszek
KGKatarzyna Gondek
Katarzyna Gondek
DGDominika Gacka
Dominika Gacka
AZAgnieszka Zalewska
Agnieszka Zalewska
ZTZuzanna Tanç
Zuzanna Tanç
Ryanodine receptor 1-related myopathies (RYR1-RM) constitute the most prevalent class of non-dystrophic congenital myopathies, representing a complex intersection of genetic heterogeneity, molecular pathology, and evolving therapeutic paradigms. Characterized by mutations in the RYR1 gene, these disorders manifest across a broad clinical spectrum ranging from static congenital weakness to life-threatening pharmacogenetic traits such as Malignant Hyperthermia Susceptibility (MHS). This review article provides an exhaustive synthesis of the scientific and societal landscape of RYR1-RM as of 2025. We provide a deep mechanistic analysis of the RyR1 channel's structure-function relationship, elucidated through recent cryo-electron microscopy breakthroughs that define the "leaky channel" pathophysiology. We critically evaluate the emerging pharmacological arsenal, including the landmark Phase 1b trial of the Rycal compound ARM210 (S48168), the novel application of epigenetic modulation via 5-aza-2'-deoxycytidine, and the repurposed utility of dantrolene and salbutamol. Furthermore, we dissect the frontier of precision genetic engineering, detailing the mechanics and efficacy of Prime Editing and Twin Prime Editing strategies, alongside the development of myotropic viral vectors (MyoAAV) designed to overcome the delivery barriers inherent to the massive RYR1 gene. Beyond the bench, this report integrates a rigorous social science perspective, analyzing the health economic frameworks (ICER, QALYs) that govern access to orphan drugs, the ethical dimensions of somatic gene editing for non-lethal disabilities, and the transformative role of patient advocacy in the rare disease ecosystem. This multidimensional review aims to serve as a foundational resource for clinicians, researchers, and policymakers navigating the complex transition from supportive care to disease-modifying precision medicine.